Pharmacist-initiated peripheral arterial disease screening program in a community pharmacy setting

Journal of the American Pharmacists Association

Volumn 51, Issue 3, 2011, Pages 373-377

  Winfrey, Cameron ^a   Wortman, Sara ^a   Frede, Stacey ^a   Kunze, Natalie ^a   Conrad, Wayne F ^b   Heaton, Pamela C ^b  

^a Kroger Patient Care Center   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Community pharmacy; Peripheral arterial disease; Pharmacy services; Screening program

Indexed keywords

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; DYSLIPIDEMIA; FEASIBILITY STUDY; FEE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; MALE; MIDDLE AGED; PATIENT COUNSELING; PATIENT REFERRAL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHARMACIST; PHARMACY; PROGRAM FEASIBILITY; PROSPECTIVE STUDY; SCREENING; AGED; DIABETIC ANGIOPATHY; DOPPLER FLOWMETRY; EVALUATION; MASS SCREENING; METHODOLOGY; ORGANIZATION AND MANAGEMENT; RISK FACTOR; UNITED STATES;

AGED; ANKLE BRACHIAL INDEX; COMMUNITY PHARMACY SERVICES; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DYSLIPIDEMIAS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; OHIO; PERIPHERAL ARTERIAL DISEASE; PHARMACISTS; PROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 84855535758     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2011.09160     Document Type: Article

References (13)

1. Criqui MH. Peripheral arterial disease: epidemiological aspects. Vasc Med. 2001;6(3 suppl):3-7.
2. Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes: report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18-20, 1992 New Orleans, Louisiana. Circulation. 1993;88:819-28.
3. Kanjwal MK, Cooper C, Bashir R. Peripheral arterial disease: the silent killer. JK Pract. 2004;11:225-32.
4. Doubeni CA, Yood RA, Emani S, Gurwitz JH. Identifying unrecognized peripheral arterial disease among asymptomatic patients in the primary care setting. Angiology. 2006;57:171-80.
5. Hirsch AT, Halverson SL, Treat-Jacobson D, et al. The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care. Vasc Med. 2001;6:87-96.
6. Zerumsky K, Steinmetz KL, Handler SM, Rodriguez EG. Pharmacist detection of peripheral arterial disease through the use of a handheld Doppler. Pharmacotherapy. 2005;25:797-802.
7. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-24.
8. Office of the Surgeon General. Acting surgeon general issues 'call to action to prevent deep vein thrombosis and pulmonary embolism.' Accessed at www.surgeongeneral.gov/news/pressreleases/pr20080915.html, September 17, 2008.
9. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333-41.
10. Egervary A. No 'I' in 'pharmacy'. Pharmacy Today. 2008;14(5):42-4.
11. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol. 1992;45:1101-9.
12. Coyne KS, Margolis MK, Gilchrist KA, et al. Evaluating effects of method of administration on Walking Impairment Questionnaire. J Vasc Surg. 2003;38:296-304.
13. Payscale, Inc. Payscale salary reports. Accessed at www.payscale.com, June 20, 2009.